Morgan Stanley下调Excelerate Energy目标价至28美元
周四，Morgan Stanley分析师调整了对Excelerate Energy Inc（NYSE:EE）的展望，将该股票的目标价从此前的29美元下调至28美元，同时维持"减持"评级。根据 InvestingPro ...
Morgan Stanley下调Petrobras目标价至$19，维持增持评级
周四，Morgan Stanley分析师Bruno Montanari将在纽约证券交易所交易的Petrobras股票（股票代码NYSE:PBR）的目标价从此前的$19.50下调至$19.00。尽管作出了这一调整，但该公司仍维持对该股票的增持评级。根据InvestingPro数据显示，Petrobras保持着"优秀"的财务健康评分3.18，分析师目标价区间为$15.00至$19.50。
分享到微信
20:40【映恩生物向港交所提交上市申请】据港交所文件，映恩生物向港交所提交上市申请，联席保荐人为摩根士丹利（Morgan Stanley）、杰富瑞（Jefferies）、中信证券。
Morgan Stanley Swiss Unit Fined $1.1 Million in Greek Bribery Case
Morgan Stanley’s Swiss unit was fined 1 million Swiss francs ($1.1 million) for failing to prevent the laundering of millions ...
Switzerland fines Morgan Stanley $1 million over 2010 money laundering case
The Swiss attorney general's office said on Thursday it had imposed a $1 million fine on Morgan Stanley's Swiss operations ...
Synopsys keeps Overweight rating at Morgan Stanley after Q1 beat
Shares of Synopsys (NASDAQ:SNPS) were largely flat on Thursday after first quarter fiscal 2025 results beat estimates which ...
SPS Commerce to Present at the Morgan Stanley Technology, Media & Telecom Conference
SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, today announced that management will ...
Wall Street giant Morgan Stanley eases diversity emphasis in annual report
Morgan Stanley also drew scrutiny previously for fielding an all-white, all-male slate of candidates to succeed former CEO ...
Pure Storage price target lowered to $69 from $72 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Pure Storage (PSTG) to $69 from $72 and keeps an Equal Weight rating on the shares. Pure beat ...
InvestmentNews2 天
Morgan Stanley’s 'key driver' is wealth management, analyst notes
The wirehouse's "strong investment in technology and AI has improved financial advisor productivity," KBW's David Konrad said ...
Block upgraded to Equal Weight by Morgan Stanley. Stock falls lower.
Block, Inc. (XYZ) received an upgrade to Equal Weight by Morgan Stanley analysts, citing the fintech company's valuation is ...
腾讯网2 天
新股消息 | 映恩生物港股IPO招股书失效
智通财经APP获悉，映恩生物(Duality Biotherapeutics, Inc.)于2024年8月26日所递交的港股招股书满6个月，于2025年2月26日失效，递表时Morgan Stanley、Jefferies、CITIC ...